Fortis Life Sciences Acquires International Point of Care

Assent Acquires IPOINT to Build Unified AI-Powered Product Compliance and Lifecycle Intelligence Platform

July 9, 2026

Software

Assent, a supply chain sustainability management and product compliance provider headquartered in Ottawa, acquired IPOINT, a Germany-based product compliance and sustainability software provider. The deal is Assent’s first acquisition and expands its platform from supply chain compliance into end-to-end product lifecycle intelligence, supporting requirements such as Digital Product Passports and EU sustainability regulations.

Eli Lilly Acquires POINT Biopharma Global

December 27, 2023

Biotechnology

Eli Lilly and Company completed the acquisition of POINT Biopharma Global Inc. after a tender offer at $12.50 per share in cash, followed by a second-step merger and delisting of POINT's common stock. The transaction brings POINT's radioligand therapy pipeline and radiopharmaceutical capabilities into Lilly's oncology research and development efforts.

Care Access Acquires Instituto Brasil de Pesquisa Clínica (IBPClin)

June 29, 2022

Healthcare Services

Care Access, a Boston-based decentralized research organization, has acquired Instituto Brasil de Pesquisa Clínica (IBPClin), a clinical trial center in Rio de Janeiro, Brazil. The acquisition is intended to expand Care Access's decentralized clinical trial delivery model and capabilities into Latin America, increasing access to trials for underserved and hard-to-reach populations.

Fortis Life Sciences Acquires Abcore

March 2, 2022

Biotechnology

Fortis Life Sciences has acquired Abcore, an antibody discovery platform specializing in nanobody technologies, to expand Fortis’ antibody product and service capabilities. The acquisition brings Abcore’s end-to-end discovery and custom antibody production capabilities into the Fortis platform to accelerate commercial and operational scale-up for biopharma and diagnostic customers.

Fortis Life Sciences Acquires nanoComposix

July 23, 2021

Biotechnology

Fortis Life Sciences completed its acquisition of nanoComposix, a San Diego–based nanomaterials company focused on assay development, diagnostics and drug-delivery applications. The deal (closed June 2021) brings nanoComposix into the Fortis Life Sciences platform to expand its life-science reagents and contract-manufacturing capabilities and create synergies across the portfolio.

PharMerica Acquires OnePoint Patient Care

October 1, 2020

Healthcare Services

PharMerica completed the acquisition of OnePoint Patient Care (OPPC), a leading independent hospice pharmacy and PBM provider. OPPC operates 15 pharmacy locations, serves more than 350 hospice programs and manages pharmacy benefits for over 32,000 patients per day; PharMerica said the deal will expand its hospice pharmacy capabilities and accelerate delivery of local same-day dispensing nationwide.